<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">34672377</PMID><DateCompleted><Year>2022</Year><Month>06</Month><Day>03</Day></DateCompleted><DateRevised><Year>2022</Year><Month>12</Month><Day>07</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1096-9071</ISSN><JournalIssue CitedMedium="Internet"><Volume>94</Volume><Issue>3</Issue><PubDate><Year>2022</Year><Month>Mar</Month></PubDate></JournalIssue><Title>Journal of medical virology</Title><ISOAbbreviation>J Med Virol</ISOAbbreviation></Journal><ArticleTitle>Long COVID syndrome-associated brain fog.</ArticleTitle><Pagination><StartPage>979</StartPage><EndPage>984</EndPage><MedlinePgn>979-984</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1002/jmv.27404</ELocationID><Abstract><AbstractText>We investigated the frequency of brain fog in a large cohort of patients with documented coronavirus disease-2019 (COVID-19) who have survived the illness. We also scrutinized the potential risk factors associated with the development of brain fog. Adult patients (18-55 years of age), who were referred to the healthcare facilities anywhere in Fars province from February 19, 2020 to November 20, 2020 were included. All patients had a confirmed COVID-19 diagnosis. In a phone call, at least 3 months after their discharge from the hospital, we obtained their current information. A questionnaire was specifically designed for data collection. In total, 2696 patients had the inclusion criteria; 1680 (62.3%) people reported long COVID syndrome (LCS). LCS-associated brain fog was reported by 194 (7.2%) patients. Female sex (odds ratio [OR]: 1.4), respiratory problems at the onset (OR: 1.9), and intensive care unit (ICU) admission (OR: 1.7) were significantly associated with reporting chronic post-COVID "brain fog" by the patients. In this large population-based study, we report that chronic post-COVID "brain fog" has significant associations with sex (female), respiratory symptoms at the onset, and the severity of the illness (ICU admission).</AbstractText><CopyrightInformation>&#xa9; 2021 Wiley Periodicals LLC.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Asadi-Pooya</LastName><ForeName>Ali A</ForeName><Initials>AA</Initials><Identifier Source="ORCID">0000-0002-2598-7601</Identifier><AffiliationInfo><Affiliation>Epilepsy Research Center, Shiraz University of Medical Sciences, Shiraz, Iran.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Neurology, Jefferson Comprehensive Epilepsy Center, Thomas Jefferson University, Philadelphia, Pennsylvania, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Akbari</LastName><ForeName>Ali</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Emami</LastName><ForeName>Amir</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Burn and Wound Healing Research Center, Shiraz University of Medical Sciences, Shiraz, Iran.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lotfi</LastName><ForeName>Mehrzad</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Medical Imaging Research Center, Shiraz University of Medical Sciences, Shiraz, Iran.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rostamihosseinkhani</LastName><ForeName>Mahtab</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Epilepsy Research Center, Shiraz University of Medical Sciences, Shiraz, Iran.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nemati</LastName><ForeName>Hamid</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Epilepsy Research Center, Shiraz University of Medical Sciences, Shiraz, Iran.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Barzegar</LastName><ForeName>Zohreh</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Epilepsy Research Center, Shiraz University of Medical Sciences, Shiraz, Iran.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kabiri</LastName><ForeName>Maryam</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Epilepsy Research Center, Shiraz University of Medical Sciences, Shiraz, Iran.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zeraatpisheh</LastName><ForeName>Zahra</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Epilepsy Research Center, Shiraz University of Medical Sciences, Shiraz, Iran.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Farjoud-Kouhanjani</LastName><ForeName>Mohsen</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Epilepsy Research Center, Shiraz University of Medical Sciences, Shiraz, Iran.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jafari</LastName><ForeName>Anahita</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Epilepsy Research Center, Shiraz University of Medical Sciences, Shiraz, Iran.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sasannia</LastName><ForeName>Sarvin</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Epilepsy Research Center, Shiraz University of Medical Sciences, Shiraz, Iran.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ashrafi</LastName><ForeName>Shayan</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Epilepsy Research Center, Shiraz University of Medical Sciences, Shiraz, Iran.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nazeri</LastName><ForeName>Masoume</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Epilepsy Research Center, Shiraz University of Medical Sciences, Shiraz, Iran.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nasiri</LastName><ForeName>Sara</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Epilepsy Research Center, Shiraz University of Medical Sciences, Shiraz, Iran.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shahisavandi</LastName><ForeName>Mina</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Epilepsy Research Center, Shiraz University of Medical Sciences, Shiraz, Iran.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>10</Month><Day>24</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Med Virol</MedlineTA><NlmUniqueID>7705876</NlmUniqueID><ISSNLinking>0146-6615</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001921" MajorTopicYN="N">Brain</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000086742" MajorTopicYN="N">COVID-19 Testing</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="N">Post-Acute COVID-19 Syndrome</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">SARS-CoV-2</Keyword><Keyword MajorTopicYN="N">brain</Keyword><Keyword MajorTopicYN="N">coronavirus</Keyword></KeywordList><CoiStatement>Ali A. Asadi&#x2010;Pooya received honoraria from Cobel Daruo, RaymandRad, and Tekaje and Royalty from Oxford University Press (book publication). Other authors have no conflict of interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="revised"><Year>2021</Year><Month>10</Month><Day>13</Day></PubMedPubDate><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>7</Month><Day>14</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>10</Month><Day>18</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>10</Month><Day>22</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>6</Month><Day>7</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>10</Month><Day>21</Day><Hour>8</Hour><Minute>48</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2021</Year><Month>10</Month><Day>24</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">34672377</ArticleId><ArticleId IdType="pmc">PMC8662118</ArticleId><ArticleId IdType="doi">10.1002/jmv.27404</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Walitt B, Bartrum E. A clinical primer for the expected and potential post&#x2010;COVID&#x2010;19 syndromes. Pain Rep. 2021;6:e887.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7889402</ArticleId><ArticleId IdType="pubmed">33615088</ArticleId></ArticleIdList></Reference><Reference><Citation>Arnold DT, Hamilton FW, Milne A, et al. Patient outcomes after hospitalisation with COVID&#x2010;19 and implications for follow&#x2010;up: results from a prospective UK cohort. Thorax. 2021;76:399&#x2010;401.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7716340</ArticleId><ArticleId IdType="pubmed">33273026</ArticleId></ArticleIdList></Reference><Reference><Citation>Accessed June 18, 2021.&#xa0;https://www.nice.org.uk/guidance/ng188/
</Citation></Reference><Reference><Citation>Raveendran AV. Long COVID&#x2010;19: Challenges in the diagnosis and proposed diagnostic criteria. Diabetes Metab Syndr. 2021;15:145&#x2010;146.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7737559</ArticleId><ArticleId IdType="pubmed">33341598</ArticleId></ArticleIdList></Reference><Reference><Citation>Asadi&#x2010;Pooya AA, Simani L. Central nervous system manifestations of COVID&#x2010;19: a systematic review. J Neurol Sci. 2020;413:116832.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7151535</ArticleId><ArticleId IdType="pubmed">32299017</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou H, Lu S, Chen J, et al. The landscape of cognitive function in recovered COVID&#x2010;19 patients. J Psychiatr Res. 2020;129:98&#x2010;102.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7324344</ArticleId><ArticleId IdType="pubmed">32912598</ArticleId></ArticleIdList></Reference><Reference><Citation>Hugon J, Msika EF, Queneau M, Farid K, Paquet C. Long COVID: cognitive complaints (brain fog) and dysfunction of the cingulate cortex. J Neurol. Published online 2021 June, 18:1&#x2010;3. 10.1007/s00415-021-10655-x</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00415-021-10655-x</ArticleId><ArticleId IdType="pmc">PMC8211714</ArticleId><ArticleId IdType="pubmed">34143277</ArticleId></ArticleIdList></Reference><Reference><Citation>Orr&#xf9; G, Bertelloni D, Diolaiuti F, et al. Long&#x2010;COVID syndrome? A study on the persistence of neurological, psychological and physiological symptoms. Healthcare (Basel). 2021;9:575.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8152255</ArticleId><ArticleId IdType="pubmed">34068009</ArticleId></ArticleIdList></Reference><Reference><Citation>Accessed July 13, 2021.&#xa0;https://www.healthline.com/health/brain-fog/
</Citation></Reference><Reference><Citation>Accessed July 13, 2021.&#xa0;https://www.merriam-webster.com/dictionary/brain%20fog/
</Citation></Reference><Reference><Citation>Accessed March 14, 2021.&#xa0;https://www.worldometers.info/coronavirus/country/iran/
</Citation></Reference><Reference><Citation>Sudre CH, Murray B, Varsavsky T, et al. Attributes and predictors of long COVID. Nat Med. 2021;27:626&#x2010;631.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7611399</ArticleId><ArticleId IdType="pubmed">33692530</ArticleId></ArticleIdList></Reference><Reference><Citation>Mandal S, Barnett J, Brill SE, et al. "Long&#x2010;COVID": a cross&#x2010;sectional study of persisting symptoms, biomarker and imaging abnormalities following hospitalisation for COVID&#x2010;19. Thorax. 2021;76:396&#x2010;398.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7615158</ArticleId><ArticleId IdType="pubmed">33172844</ArticleId></ArticleIdList></Reference><Reference><Citation>Morin L, Savale L, Pham T, et al. Four&#x2010;month clinical status of a cohort of patients after hospitalization for COVID&#x2010;19. JAMA. 2021;325:1525&#x2010;1534.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7970386</ArticleId><ArticleId IdType="pubmed">33729425</ArticleId></ArticleIdList></Reference><Reference><Citation>Miskowiak KW, Johnsen S, Sattler SM, et al. Cognitive impairments four months after COVID&#x2010;19 hospital discharge: pattern, severity and association with illness variables. Eur Neuropsychopharmacol. 2021;46:39&#x2010;48.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8006192</ArticleId><ArticleId IdType="pubmed">33823427</ArticleId></ArticleIdList></Reference><Reference><Citation>Hellmuth J, Barnett TA, Asken BM, et al. Persistent COVID&#x2010;19&#x2010;associated neurocognitive symptoms in non&#x2010;hospitalized patients. J Neurovirol. 2021;27:191&#x2010;195.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7852463</ArticleId><ArticleId IdType="pubmed">33528824</ArticleId></ArticleIdList></Reference><Reference><Citation>Peghin M, Palese A, Venturini M, et al. Post&#x2010;COVID&#x2010;19 symptoms 6 months after acute infection among hospitalized and non&#x2010;hospitalized patients. Clin Microbiol Infect. 2021;27:1507&#x2010;1513.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8180450</ArticleId><ArticleId IdType="pubmed">34111579</ArticleId></ArticleIdList></Reference><Reference><Citation>Sykes DL, Holdsworth L, Jawad N, Gunasekera P, Morice AH, Crooks MG. Post&#x2010;COVID&#x2010;19 symptom burden: what is long&#x2010;COVID and how should we manage it? Lung. 2021;199:113&#x2010;119.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7875681</ArticleId><ArticleId IdType="pubmed">33569660</ArticleId></ArticleIdList></Reference><Reference><Citation>Guedj E, Campion JY, Dudouet P, et al. 18F&#x2010;FDG brain PET hypometabolism in patients with long COVID. Eur J Nucl Med Mol Imaging. 2021;48:2823&#x2010;2833.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7837643</ArticleId><ArticleId IdType="pubmed">33501506</ArticleId></ArticleIdList></Reference><Reference><Citation>Batabyal R, Freishtat N, Hill E, Rehman M, Freishtat R, Koutroulis I. Metabolic dysfunction and immunometabolism in COVID&#x2010;19 pathophysiology and therapeutics. Int J Obes (Lond). 2021;45:1163&#x2010;1169.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7961323</ArticleId><ArticleId IdType="pubmed">33727631</ArticleId></ArticleIdList></Reference><Reference><Citation>Stefano GB, Ptacek R, Ptackova H, Martin A, Kream RM. Selective neuronal mitochondrial targeting in SARS&#x2010;CoV&#x2010;2 infection affects cognitive processes to induce &#x201c;brain fog&#x201d; and results in behavioral changes that favor viral survival. Med Sci Monit. 2021;27:e930886.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7845145</ArticleId><ArticleId IdType="pubmed">33487628</ArticleId></ArticleIdList></Reference><Reference><Citation>Humphreys H, Kilby L, Kudiersky N, Copeland R. Long COVID and the role of physical activity: a qualitative study. BMJ Open. 2021;11:e047632.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7948149</ArticleId><ArticleId IdType="pubmed">33692189</ArticleId></ArticleIdList></Reference><Reference><Citation>Frontera JA, Yang D, Lewis A, et al. A prospective study of long&#x2010;term outcomes among hospitalized COVID&#x2010;19 patients with and without neurological complications. J Neurol Sci. 2021;426:117486.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8113108</ArticleId><ArticleId IdType="pubmed">34000678</ArticleId></ArticleIdList></Reference><Reference><Citation>Theoharides TC, Cholevas C, Polyzoidis K, Politis A. Long&#x2010;COVID syndrome&#x2010;associated brain fog and chemofog: luteolin to the rescue. Biofactors. 2021;47:232&#x2010;241.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8250989</ArticleId><ArticleId IdType="pubmed">33847020</ArticleId></ArticleIdList></Reference><Reference><Citation>Theoharides TC, Conti P. Be aware of SARS&#x2010;CoV&#x2010;2 spike protein: there is more than meets the eye. J Biol Regul Homeost Agents. 2021;35:833&#x2010;838.</Citation><ArticleIdList><ArticleId IdType="pubmed">34100279</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>